Thrombosis and Thromboembolism 2021

Thrombosis and Thromboembolism 2021 is organized by Harvard Medical School (HMS) and will be held from Oct 07 - 08, 2021 at Hotel Fairmont Copley Plaza, Boston, Massachusetts, United States of America. This Conference has been approved for a maximum of 15.75 CME Credits. Description:The State of the Art for Prevention, Evaluation, and TreatmentThis special Harvard Medical School CME course, offered only occasionally, provides a comprehensive review of the most important changes and advances impacting the care of patients who have—or are at risk for—thrombosis and thromboembolism. Updates in diagnosis, treatment and prevention are provided by world-renowned experts and Harvard Medical School’s leading clinical faculty. The curriculum includes: • New options for testing and diagnosis of thrombotic disorders• Important developments in epidemiology and pathophysiology• Best practices for stroke prevention (and prediction) in atrial fibrillation• Guidance to navigate the nuances of prescribing dual antiplatelet therapy• When and how to use new oral anticoagulants and interventional devices• Personalized medicine and lipid biology• Updated lipid guidelines (and controversies surrounding them)• Expert advice to incorporate the latest science into your practice This program has provided practical and timely education about innovations in this field since 1987. First-time and returning attendees consistently report that the knowledge they acquire from this update changes their practice and drives better outcomes for patients. Participants will learn state-of-the-art approaches to preventing VTE in medically ill patients; how dual anti-platelet therapy can prevent MI, stroke, and leg amputation; improved stroke prediction and prevention; and a better understanding of the link between inflammation and thrombotic illnesses. Program Highlights:The 2020 postponed program was slated to include coverage of the most exciting new predictive, diagnostic and treatment options, including genetics, cardio-oncology, thrombophilia, and personalized medicine:• DVT/PE diagnosis, testing, parenteral and oral anticoagulants• Atherothrombosis: etiology, pathophysiology, therapy• Infertility and hypercoagulability: testing and management• Lipid biology, especially triglycerides and lipoprotein(a)• Dual antiplatelet therapy: dose, duration, reversibility• Stroke prevention (and prediction) in atrial fibrillation• Nutrition and thrombosis• Diabetes and metabolic syndrome and thrombosis• Pulmonary hypertension• Heart failure with preserved or reduced ejection fraction This program is among the highest-rated Harvard Medical School CME courses. Please note that this course is only offered occasionally, and seating is limited. To ensure a spot, early registration is strongly recommended. Learning Objectives:Upon completion of this course, participants will be able to:• Identify the etiology and pathophysiology of atherothrombosis • Recognize the link between inflammation and thrombotic illnesses• Explain new tools for stroke prevention (and stroke prediction) in atrial fibrillation• Identify the optimal duration of anticoagulation for PE and DVT• Provide advanced therapy beyond anticoagulation in PE and DVT: thrombolysis, catheter-directed therapy,surgical embolectomy• Explain the connection between diabetes, metabolic syndrome, and major adverse cardiac events• Provide patients with useful insights into how a heart-healthy diet can help prevent thrombosis• Manage a high-risk pregnancy View All10 Speaking Scott David Solomon Cardiology Paul M. Ridker Cardiology Galen Vincent Henderson Neurology Piotr Stefan Sobieszczyk Cardiology 1Tracking Casandra Cashman Family Medicine